Loading
Latest filing published 28 Mar 2023 for Pharma-Bio Serv, Inc., €18k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Irving L. Wiesen (board member) discloses dealings in Pharma-Bio Serv, Inc. to SEC (Form 4). We count 6 filings; the first trade dates from 2 January 2016 and the latest from 24 March 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 28 March 2023, the filings show an option exercise worth €18k in Pharma-Bio Serv, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations